BACKGROUND
The effect of transcatheter tricuspid-valve repair on clinical outcomes, including death and hospitalization for heart failure, in patients with severe tricuspid regurgitation remains uncertain.
METHODS
We randomly assigned patients with symptomatic severe tricuspid regurgitation and an increased risk of f...
J. Hausleiter, T. Stocker, Tobias Geisler et al.· New England Journal of Medic...· 8 citations· ⚡1
OBJECTIVES
Tricuspid regurgitation (TR) is associated with high morbidity and mortality. The TricValve bicaval valve system has emerged as a transcatheter option for patients with severe symptomatic TR who are not candidates for surgery or orthotopic interventions. However, its safety in patients with pre-existing card...
K. Osipenko, Iuliana Coti, Paul Werner et al.· European Journal of Cardio-T...· 0 citations
BACKGROUND
Data on early outcomes of the novel balloon-expandable (BE) Octapro transcatheter heart valve (THV) in real-world practice are limited. We sought to assess procedural safety and early outcomes of the Octapro in patients with severe native aortic stenosis (AS) undergoing transcatheter aortic valve implantatio...
A. Ielasi, E. Moscarella, Gregor Verček et al.· International Journal of Car...· 0 citations
TTVR with both, the Cardiovalve and EVOQUE prothesis is an effective treatment option, leading to profound TR reduction and meaningful clinical improvement at 30-day follow-up.
Florian Genske, Judith Heine, C. Marquetand et al.· Frontiers in Cardiovascular...· 0 citations
LVSWI is a robust, independent prognostic marker after T-TEER, whereas RVSWI alone lacks predictive value, and incorporation of stroke work indices into pre-procedural assessment may refine risk stratification and optimize management strategies in T-TEER candidates.
U. Hanses, Kathrin Diehl, Shiyar Alo et al.· Canadian Journal of Cardiolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
